Trial Details

Not Recruiting
Basic Information
Clinical ID c2837
Identifier ISRCTN11314352
Trial Title Evaluation of faecal volatile organic compounds in the diagnosis of paediatric inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions Inflammatory bowel disease and common gastrointestinal disorders in children referred for specialist paediatric gastroenterology review Digestive System Inflammatory bowel disease
Interventions Potential participants will be identified by their clinical team by reviewing referrals to out-patient clinics, children attending for ward review or referred directly for investigations such as endoscopy. Children will be asked to collect a stool sample to bring to the hospital. Stool samples will be used for the measurement of calprotectin for the assessment of intestinal inflammation as part of routine clinical practice. Following informed consent, an aliquot of the stool sample will be stored for the measurement of VOCs at the end of the study. Faecal VOCs will be measured by two methods: i) headspace SPME-Combipal GCMS and ii) the GC-sensor doreader The clinical team will undertake investigations as appropriate to determine the diagnosis/diagnoses. The clinical records of all children will be reviewed 3 months after recruitment to record the results of investigations and diagnoses. In children who are diagnosed with inflammatory bowel disease, the follow-up at 3 months will also assess disease activity and record the treatment that they have received.
Participant Information
Sponsor Alder Hey Children NHS Foundation Trust
City -
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2020-06-30